Clinical trial
A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of…
NCT00290134 · QuatRx Pharmaceuticals Company, Industry · Completed
Key facts
| NCT number | NCT00290134 |
|---|---|
| Title | A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism |
| Official title | Preliminary Efficacy and Safety of Fispemifene in the Treatment of Hypogonadism: A 4 Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing Daily Oral Doses of 100, 200, and 300 mg Fispemifene and Placebo |
| Lead sponsor | QuatRx Pharmaceuticals Company, Industry |
| Collaborators | Hormos Medical Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypogonadism |
| Intervention type | Drug |
| Interventions | Fispemifene once daily for 4 weeks |
| Enrollment | 100 |
| Start date | Feb 1, 2006 |
| Completion | Oct 1, 2007 |
| First posted | Feb 10, 2006 |
| Last update posted | Mar 3, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: